The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
Pharmacoeconomic assessment of Pegaspargase versus Asparaginase in acute lymphocytic leukemia
Estimación del coste de administración de Rituximab para el tratamiento de Linfomas No Hodking en hospitales de día del SNS
Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010
